Literature DB >> 23546040

Rare occurrence of bilateral breast and peritoneal metastases from osteogenic sarcoma.

Ruoh Shyuan Chan1, Gnana Kumar, Anushya A P Vijayananthan.   

Abstract

Breast metastases are uncommon and typically spread from contralateral breast carcinomas. Breast metastases that spread from extramammary malignancies are even less common, and account for 0.5%-6.6% of all malignant breast disease. As extrapulmonary metastases from osteosarcoma are uncommon, breast metastasis from osteosarcoma is extremely rare. We report a case of breast and peritoneal metastases from a tibial osteosarcoma 18 months after diagnosis, and 9 months after surgery and adjuvant chemotherapy. Computed tomography findings of multiple calcified and noncalcified tumour deposits in the lungs, pleura, peritoneum, chest wall and both breasts are described.

Entities:  

Mesh:

Year:  2013        PMID: 23546040     DOI: 10.11622/smedj.2013060

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  4 in total

1.  Unusual abdominal metastases in osteosarcoma.

Authors:  Simon Berhe; Enrico Danzer; Paul Meyers; Gerald Behr; Michael P LaQuaglia; Anita P Price
Journal:  J Pediatr Surg Case Rep       Date:  2018-01

2.  Metastasis of Osteosarcoma to the Abdomen: A Report of Two Cases and a Review of the Literature.

Authors:  Robert Serpico; Jeffrey Brown; Alan Blank; Kevin Jones; R Lor Randall; John Groundland
Journal:  Case Rep Oncol       Date:  2021-03-31

3.  Metastatic Osteosarcoma to the Breast Presenting as a Densely Calcified Mass on Mammography.

Authors:  Jonghyeon Kim; Ha Young Woo; Eun-Kyung Kim; Min Jung Kim; Hee Jung Moon; Jung Hyun Yoon
Journal:  J Breast Cancer       Date:  2016-03-25       Impact factor: 3.588

4.  Synchronous lung and multiple soft tissue metastases developed from osteosarcoma of tibia: a rare case report and genetic profile analysis.

Authors:  Chuanxi Zheng; Yitian Wang; Yi Luo; Zongguo Pang; Yong Zhou; Li Min; Chongqi Tu
Journal:  BMC Musculoskelet Disord       Date:  2022-01-20       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.